Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00568789 · ClinicalTrials.gov registry record · Phase 4
Safety of Ramelteon in Elderly Subjects
A Phase 4 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 4
- Development phase
- 33
- Enrollment target
NCT00568789 is a Phase 4 study that has completed, run by Takeda. The registered enrollment target is 33 participants.
The verdict
NCT00568789, a Phase 4 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effects of ramelteon in elderly subjects on balance, mobility and memory impairment after awakening in the middle of the night following bedtime dosing.
Interventions
- DRUG Ramelteon, zolpidem and placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2006-06 |
| Est. Completion | 2006-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00568789
The ClinicalTrials.gov registry entry for NCT00568789 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ramelteon, zolpidem and placebo is the first listed.
NCT00568789 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00568789 about?
NCT00568789 is a clinical study titled "Safety of Ramelteon in Elderly Subjects". The purpose of this study is to investigate the effects of ramelteon in elderly subjects on balance, mobility and memory impairment after awakening in the middle of the night following bedtime dosing.
What is the current status of trial NCT00568789?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 33 participants. The study started on 2006-06. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00568789?
The interventions under investigation include: Ramelteon, zolpidem and placebo (DRUG).
Who is sponsoring clinical trial NCT00568789?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.